BSPM - Biostar Pharmaceuticals

Industry: Drug Manufacturers - Major Sector: Healthcare Exchange: NASDAQ

BSPM - Biostar Pharmaceuticals

Industry: Drug Manufacturers - Major Sector: Healthcare Exchange: NASDAQ
#6229()/7561

Tue 14'th Aug 2018

PERIOD 2018-05-15 - 2018-08-14
CHANGE -0.99%
PRICE $2.00
VOLUME
Sell
TREND
Sell

MV LONG
Sell

MV SHORT
Buy

PIVOT
Sell

MACD
Buy

Request Prediction
0.00%
Predict

Biostar Pharmaceuticals Stock Analysis

Technical stock analysis for Tue 14'th Aug 2018

Sell candidate since 2018-08-14
Shorts 0.38% ( 2018-07-31 )
Cash n/a
Loans n/a
Beta 2.38
ROA 2.28

Biostar Pharmaceuticals fell by -0.99% in the last day from $2.02 to $2.00 The price has fallen in 6 of the last 10 days , but is still up by 6.95% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -50 016 shares and in total 82 364 shares bought and sold for approximately $164 728.00.

Trend

Biostar Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -19.78% during the next 3 months and, with 90% probability hold a price between $0.96 and $1.94 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Some negative signals were issued as well, and these may have some influence on the near short-term development. Biostar Pharmaceuticals holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $2.11. On a fall, the stock will find some support from the short-term average at $1.92. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Monday August 13, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 67 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Biostar Pharmaceuticals finds support from accumulated volume at $1.95.

Support: $1.95 Price: $2.00 Resistance: $2.31

Risk

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.24 between high and low, or 12.97%. For the last week the stock has had a daily average volatility of 10.78%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation

Biostar Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.

Sell Candidate

Click for Top 5 Sell Candidates
Help us IMPROVE our CHARTS HERE.

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at


in partnership with
START FREE 5-DAY TRIAL